Nobel laureate Joshua Lederberg wrote, “The future of humanity and microbes will likely evolve as … episodes of our wits vs their genes”. According to the latest report from WHO (World Health Organization) Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. Because the drivers of antimicrobial resistance lie in humans, animals, plants, food and the environment, a sustained One Health response is essential to engage and unite all stakeholders around a shared vision and goals. “At Theomics, we have developed rapid quantitative and qualitative screening of all the known antimicrobial resistance genes from environmental samples. We have developed our proprietary AMRgenes panel, which works seamlessly with Illumina MiSEQ deep sequencing platform to quickly, quantitatively and qualitatively screen AMR genes in a sample. We have optimized screening of upto 100 samples in a week and we expect the cost for screening a single sample to be as low as $99.”